ClinicalTrials.gg
RecruitingNCT07460973NE+Updated May 12, 2026

Nen ŨnkUmbi/EdaHiYedo Plus (We Are Here Now Plus): a Multi-level Intervention to Reduce Health Disparities Among American Indian Youth

An interventional study of NE+ and Control in Healthy, Condom Use and Mental Health, sponsored by Montana State University. Recruiting at 1 site in United States. Open to participants aged 12 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-12.

Primary conditionPsychological Well-Being(the registry's first term)UnverifiedIs this wrong?Psychological Well-Being is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Montana State University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
843
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

We Are Here Now - Plus (NE+) is a holistic, culturally centered, and multilevel intervention for American Indian youth to improve sexual health, mental health, and substance use outcomes. The goal of this intervention is to learn if NE+ can decrease substance use during sex, decrease sexual activity, increase condom use, increase positive mental health, increase caregiver(parent)-youth communication, increase communication between school personnel and youth, and increase utilization of clinical services. Researchers will compare one intervention arm to one control arm to see if the aforementioned indicators improve among the intervention arm for youth participants.

Youth participants (ages 12-18) will participate in a 9-month educational program consisting of 18 modules that discuss healthy relationships, puberty \& physiology (separate girls \& boys), parenting, pregnancy and sexually transmitted infections (STIs) and Human Immunodeficiency Virus (HIV) prevention, sexual avoidant behaviors with a focus on abstinence, substance use prevention with a focus on abstinence and refusal skills, \& positive mental health, resources; skills (high school)- self-efficacy, refusal skills, decision making, communication, abstinence; skills (middle school) - health knowledge, self-efficacy, boundaries, communication, abstinence. Youth will also participate in six teachings offered by local cultural leaders that coincide with educational modules, including: kinship networks \& family; cultural values; 7 sacred roles of tribal members; ceremonies; cultural teachings and responsibilities of women \& men in tribe \& ceremonies; Indigenous worldview; skills - knowledge of traditional ways, language \& cultural people to go to for help; community members roles \& responsibilities in tribe \& ceremonies.

Caregiver (parent) participants will participate in three in-person visits/meetings to discuss the following: visit 1 - age specific physical, cognitive, emotional, spiritual development; visit 2: prevention of substance use, promoting positive mental health, promotion of healthy relationships; skills -communication with youth; visit 3 - pregnancy and STIs/HIV prevention and abstinence from sex, parental monitoring, tribal resources.

School personnel participants will participate in three workshops during teacher in-service training days, including the following information: Workshop 1 - cultural teachings on kinship \& family networks, cultural values, cultural age \& community roles; Workshop 2 - sexual risk avoidant behaviors, substance use prevention, positive mental health promotion, pregnancy STIs/HIV prevention, tribal resources; Workshop 3 - culturally respectful communication skills by age \& youth (boy/girl) and age \& caregiver (male/female); skills - knowledge of cultural ways, substance use prevention, positive mental health promotion, sexual risk avoidant behaviors, culturally respectful communication.

02

Conditions studied

  • Healthy
  • Condom Use
  • Mental Health
  • Substance Use (Drugs, Alcohol)

Browse trials for

Keywords

  • Sexual and reproductive health
  • Mental health
  • Substance use
03

In context

Psychological Well-Being Unverified

2,193 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

This study's planned enrollment of 843 is above the median of 110 across 1,796 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

Montana State University is the lead sponsor of 42 studies on the registry; 10 are open to participants now.

Compared within Psychological Well-Being, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 12 to 18 years old
  • Registered member of a federally recognized tribe or an associate tribal member
  • Resident of the Fort Peck Reservation with a caregiver who agrees for their child to participate in the intervention

Exclusion criteria

Exclusion Criteria:

  • Not meeting any of the aforementioned inclusion criteria
  • Having a medically identified physical or cognitive impairment that would impede their understanding of and participation in the educational content, activities, and teachings of the intervention
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
843 participants (estimated)

Study arms

  • Experimental
    NE+ intervention

    Behavioral: NE+

  • Placebo comparator
    Control

    Behavioral: Control

Interventions

  • BehavioralNE+

    School-based learning intervention consisting of 18 learning modules taught over 9 months.

  • BehavioralControl

    Participants will not receive any educational material in this arm and will only provide survey responses to act as control observations.

06

What researchers measure

Primary outcomes

  1. Change from baseline in mean condom use frequency relative to sexual intercourse frequency in the past month

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  2. Change from baseline in mean number of participants reporting if they have ever had sexual intercourse

    Measuring the mean number of youth who report having ever had sex to examine if youth in the intervention arm have less initiation of sexual intercourse compared to youth in control arm.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  3. Change from baseline in mean age when participants first engage in sexual intercourse

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  4. Change from baseline in mean number of lifetime sex partners

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  5. Change from baseline in mean number of recent (past-month) sex partners

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  6. Change from baseline in mean number of times participants recently (in the past month) engaged in sexual intercourse

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  7. Change from baseline in mean number of times birth control was used during sexual intercourse

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  8. Change from baseline in mean depressive symptoms score

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  9. Change in baseline in mean number of youth who have ever smoked a cigarette

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  10. Change from baseline in mean anxiety score

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  11. Change from baseline in mean age of youth initiating tobacco use

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  12. Change from baseline in mean number of days (of past 30 days) youth reported smoking cigarettes

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  13. Change from baseline in mean number of youth who reported ever using an electronic vapor product

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  14. Change from baseline in mean number of times injection drugs were used in past 30 days

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  15. Change from baseline in mean number of times injection drugs were used in lifetime

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  16. Change from baseline in mean number of times hallucinogenic drugs were used in past 30 days

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  17. Change from baseline in mean number of times ecstasy was used in past 30 days

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  18. Change from baseline in mean number of times methamphetamines were used in past 30 days

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  19. Change from baseline in mean number of times heroin was used in past 30 days

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  20. Change from baseline in mean number of times glue, aerosol spray, or other inhalants were used in past 30 days

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  21. Change from baseline in mean number of times cocaine was used in past 30 days

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  22. Change from baseline in mean number of times hallucinogenic drugs (e.g., acid) were used in lifetime

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  23. Change from baseline in mean number of times ecstasy was used in lifetime

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  24. Change from baseline in mean number of times methamphetamines were used in lifetime

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  25. Change from baseline in mean number of times heroin was used in lifetime

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  26. Change from baseline in mean number of times glue, aerosol spray, or other inhalants were used in lifetime

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  27. Change from baseline in mean number of times any form of cocaine has been used in lifetime

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  28. Change from baseline in mean number of times prescription pain medicine without doctor's prescription was used in the past 30 days

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  29. Change from baseline in mean number of times prescription pain medicine was used without a doctor's prescription in lifetime

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  30. Change from baseline in mean number of times in the past 30 days youth reported using marijuana

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  31. Change from baseline in mean age at which youth reported first using marijuana for the first time

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  32. Change from baseline in mean number of times youth reported using marijuana in their life

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  33. Change from baseline in mean number of drinks (in the past 30 days) that youth reported having in a row

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  34. Change from baseline in mean number of days (in past 30 days) youth reported having 4 or more drinks of alcohol in a row (for males) or 5 or more drinks of alcohol in a row (for females)

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  35. Change from baseline in mean number of days (in past 30 days) youth reported having at least one drink of alcohol

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  36. Change from baseline in the mean age at which youth reported having alcohol for the first time

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  37. Change from baseline in mean number of days (in past 30 days) youth reported using an electronic vapor product

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

Secondary outcomes

  1. Change from baseline in mean condom use self-efficacy score derived from Talashek's Condom Use Self Efficacy Scale

    Talashek's condom use self-efficacy scale consists of 6 questions regarding condom use self-efficacy (e.g., "I could get condoms") with likert-type responses ranging from 1-5 (1 Yes, I could; 2 Maybe I could; 3 Don't Know; 4 Probably I could not; 5 No, I could not). Scores from each item will be summed to create a sum score between 5 and 30.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  2. Change from baseline in mean condom use intention score derived from one question with a likert-type response set from the Youth Health Risk Behavioral Inventory

    One single question asks youth how likely it is that they intend to use a condom the next time they have sex, assessed by a likert-type response set of answers ranging from 1-5, where 1 is the least likely and 5 is the most likely.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  3. Change from baseline in mean beliefs about birth control score from the pathways of choice survey

    18 questions from the pathways of choice survey, each with a likert-type response set (1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree) will be summed to create a composite score between 18 and 90.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  4. Change from baseline in mean score of knowledge of healthy relationships from the Native STAND (students together against negative decisions) survey

    10 questions from the Native STAND survey ask participants if a certain characteristic is representative of a healthy relationship. Participants respond "no" or "yes", where answers of "no" are coded to 0 and "yes" coded to 1. All answers will be summed to create a composite score from 0 to 10.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  5. Change from baseline in mean sexual refusal score derived from a sexual refusal scale from the sexual refusal skills regarding sex

    Participants are asked 7 questions pertaining to their confidence in being able to refuse sex in different scenarios. The responses range from 1-5 (1, I Definitely Can Say No; 2, I Can Say No; 3, I Don't Know; 4, I Can't Say No; 5, I Definitely Can't Say No). All responses will be summed to create a composite score ranging from 7 to 35.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  6. Change from baseline in mean score on knowledge of sexually transmitted infections and other sexual health items

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  7. Change from baseline in mean caregiver-youth communication score derived from the Parent-Adolescent Communication Scale

    Participants are asked 5 questions about how often they speak with their parents about topics regarding sexual health (e.g., "In the past 6 months, how often have you and y our parent(s) talked about how to use condoms?"), where responses range from 0=never, 1=rarely, 2=sometimes, and 3=often. Responses are summed to create a composite score ranging from 0 to 15.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  8. Change from baseline in mean caregiver-adolescent openness score derived from the Parent-adolescent communication scale

    Participants are asked 10 questions regarding their openness with their parents (e.g., "I can discuss my beliefs with my mother/father without feeling restrained or embarrassed"), where responses are: 1, Strongly disagree; 2, Somewhat disagree; 3, Neither disagree nor agree; 4, Somewhat agree; 5, Strongly agree. Responses will be summed to create a composite score ranging from 10 to 50.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  9. Change from baseline in mean cultural connectedness score derive from the cultural connectedness scale (short form)

    Participants are asked 10 questions regarding how connected they feel to their culture in three different domains (identity, spirituality, and traditions). Response sets include 1=yes and 0=no, as well as likert-type responses (1=strongly disagree, 2=somewhat disagree, 3=neither agree nor disagree, 4=somewhat agree, 5=strongly agree). Responses will be summed to create a composite score for cultural connectedness ranging from 0 to 30.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  10. Change from baseline in mean communication score between youth and school personnel derived from an adapted Ambulatory Care Experiences (ACE) survey.

    Participants are asked 8 questions about their communication and relationship with school personnel, with response sets from 1, Strongly disagree; 2, Somewhat disagree; 3, Neither disagree nor agree; 4, Somewhat agree; 5, Strongly agree. Responses will be summed to create a composite score from 8 to 40.

    Time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

07

Study locations

1 of 1 sites recruiting
  • Fort Peck Community College
    Bozeman, Montana 59715, United States
    Recruiting
    • Olivia Johnson, MA · Contactojohnson@fpcc.edu · 406-786-7427
    • Ashley Solheim-Azure, AA · Contactaazure@fpcc.edu · (406)480-9389
    • Robyn Baker, MA · Principal investigator
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for May 2029, 37 months after the start.

Of 1,259 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 37 months is above that.

Counting every sponsor, half of 1,302 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2026
First posted
Mar 10, 2026
StartActual
Mar 23, 2026
Primary completionEst.
May 1, 2029
CompletionEst.
May 1, 2029
Last update
May 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07460973
Lead sponsor
Montana State University
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD), Northern Arizona University, Mathematica Policy Research, Inc., Fort Peck Community College
Responsible party
Sponsor
First posted
Mar 10, 2026
Start date
Mar 23, 2026
Primary completion
May 1, 2029 (estimated)
Completion
May 1, 2029 (estimated)
Last update
May 12, 2026

Study contacts

Elizabeth L Rink, PhD, MSW
Contact
elizabeth.rink@montana.edu
406-600-0297
Molly Secor, PhD
Contact
molly.secor@montana.edu
Elizabeth L Rink, PhD, MSW
principal investigator · Montana State University
Julie Baldwin, PhD
principal investigator · Northern Arizona University
Molly Secor, PhD
principal investigator · Montana State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion